Tekla Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $15.8M | Buy |
|
|||||
|
2023
Q1 | $8.91M | Buy |
|
|||||
|
2022
Q4 | $3.43M | Sell |
|
|||||
|
2022
Q3 | $18.2M | Sell |
|
|||||
|
2022
Q2 | $14.1M | Buy |
|
|||||
|
2022
Q1 | $9.95M | Hold |
|
|||||
|
2021
Q4 | $9.26M | Hold |
|
|||||
|
2021
Q3 | $6.45M | Buy |
|
|||||
|
2021
Q2 | $9.64M | Hold |
|
|||||
|
2021
Q1 | $6.54M | Sell |
|
|||||
|
2020
Q4 | $12.4M | Hold |
|
|||||
|
2020
Q3 | $6.52M | Buy |
|
|||||
|
2020
Q2 | $5.67M | Hold |
|
|||||
|
2020
Q1 | $4.65M | Buy |
|
|||||
|
2019
Q4 | $4.01M | Buy |
|
|||||
|
2019
Q3 | $2.38M | Buy |
|